Endothelial cell loss is a critical event in the pathological repair of the injured blood vessel. Impaired endothelial function results in reduced production of key vascular mediators such as nitric oxide (NO) within the vessel wall leading to enhanced smooth muscle cell proliferation and migration and ultimately intimal hyperplasia. The aim of the present study was to directly compare the effects of adenoviral-mediated gene delivery of two nitric oxide synthase (NOS) isoforms, eNOS and iNOS on endothelial regeneration and intimal hyperplasia following endothelial injury in the rabbit carotid artery. The right carotid arteries of male New Zealand white rabbits were denuded by passing a 3French Fogarty balloon catheter along the artery three times. In all, 1 Â 10 9 PFU of adenoviral(Ad)eNOS, AdiNOS or Adb-galactosidase (Adb-Gal) was then delivered intraluminally and allowed to dwell for 20 min. Transgene expression was sought after 3 days by immunohistochemistry and at 7 days by quantitative reverse transcriptase PCR.
Introduction
Atherosclerosis remains the most common cause of death in the western world. Percutaneous transluminal coronary angioplasty (PTCA) has been successfully used to treat patients with occlusive coronary artery disease for over 20 years. However, post-angioplasty restenosis represents a major limitation of the procedure with more than 20% of patients requiring a further revascularization procedure within 6 months. 1 Neointimal thickening following vascular injury is a major contributory factor in post-angioplasty restenosis, a process which results from dysregulated smooth muscle cell proliferation and migration. 2 Disruption of the endothelial layer following angioplasty procedures has also been implicated in the pathological repair of injured blood vessels. 3 Impaired endothelial function leads to reduced production of key vascular mediators such as nitric oxide (NO) resulting in increased smooth muscle cell proliferation and migration, platelet adhesion and impaired endotheliumdependant vasorelaxation (EDVR). 4 All of the above processes are significant elements in the pathological repair of the injured artery following angioplasty procedures ultimately resulting in intimal hyperplasia.
Many investigators have explored the possibility of improving neointimal formation by inhibiting smooth muscle cell proliferation and migration resulting in a large number of papers published in the field. Most successful strategies have reduced neointimal hyperplasia but many also impair endothelial function resulting in an increased risk of thrombosis. However, due to the pivotal role that impaired endothelial function plays in the pathological repair of injured vessels it has been hypothesized that there may be significant therapeutic benefit in strategies which attempt to promote endothelial regeneration in injured vessels. 5 Such strategies would lead to increased production of NO and other vascular mediators which would in turn reduce smooth muscle cell proliferation, decrease oxidative stress within the vessel wall, improve vascular tone and ultimately inhibit neointimal formation. The ideal therapeutic intervention for the prevention of intimal hyperplasia and restenosis would be a strategy that would on the one hand inhibit smooth muscle cell proliferation while simultaneously promoting endothelial cell proliferation and regeneration of the injured endothelium. At the very least a strategy, which inhibits smooth muscle cell proliferation but does not impair endothelial regeneration would be desirable. To this end, we hypothesize that nitric oxide synthase (NOS) gene delivery to the injured vessel wall following angioplasty procedures may be one such therapeutic approach which could achieve these joint goals.
NO is key mediator in maintaining vascular homeostasis, as it has a number of anti-atherogenic properties including inhibition of platelet and monocyte adhesion, 6, 7 and smooth muscle cell proliferation and migration. 8, 9 NO is also potent vasodilator acting to maintain vascular tone and function within the vessel wall. Many vascular diseases are associated with reduced NO bioavailability and NOS gene therapy is a promising therapeutic approach to such maladies as it allows delivery of functional NOS genes to a localized segment of the vasculature in order to increase NO bioavailability within the blood vessel wall. 10 We have previously reported beneficial effects of eNOS gene delivery in several disease settings including hypercholesterolemia, diabetes mellitus, atherosclerosis, hypoxia, cerebral vasospasm and subarachnoid hemorrhage. [11] [12] [13] [14] [15] [16] The aim of the current study was to directly compare the effects of adenoviral-mediated overexpression of two NOS isoforms, eNOS and iNOS, on endothelial regeneration and intimal hyperplasia following denudation of the rabbit carotid artery.
Results

Detection of NOS isoform expression
Carotid arteries transduced with adenoviral b-galactosidase (Adb-Gal) as well as adenoviral eNOS (AdeNOS) or adenoviral iNOS (AdiNOS) were harvested 1 week postinjury. Following quantitative reverse transcriptase PCR analysis, which normalized the levels of NOS isoform transcript to a house-keeping gene and Adb-Gal controls, a high level of iNOS and eNOS expression could be observed in 5/7 arteries examined ( Figure 1 ). RNA obtained from these tissue samples demonstrated the presence of the appropriate sized-band for both iNOS and eNOS in 6/7 arteries tested following quantitative reverse transcriptase PCR (data not shown).
Histological localization and level of b-Gal expression
Injured carotid arteries were transduced with 1 Â 10 9 PFU/ml of Adb-Gal in 200 ml of PBS. Three days after gene delivery, b-Gal expression was sought using X-Gal staining. b-Gal expression was detected on the luminal surface of the injured carotid artery in the upper medial layer of the denuded vessel as evidenced by blue cells (Figure 2a and c) . Some adventitial expression of b-Gal was also detected, likely due to overspill during the administration of viral solution. In contrast b-Gal expression was not detected in control sections ( Figure  2b and d). Transgene expression was noted over 6.5% of the luminal surface when arteries were opened longitudinally (Figure 2e ). Significant expression can also be seen in the adventitial layer.
Localization of NOS gene expression
To investigate the localization of eNOS and iNOS expression in the injured carotid artery immunohistochemistry was performed on frozen tissue sections 3 days after injury. eNOS and iNOS expression were detected in the media and the adventitia of the AdeNOS and AdiNOS-transduced arteries, respectively. In contrast, there was no staining for either eNOS or iNOS in Adb-Gal-transduced arteries (Figure 3 ).
Effect of eNOS and iNOS gene transfer on endothelial regeneration
Two weeks after injury and local gene delivery, endothelial regeneration was assessed by Evans blue staining ( Figure 4 ). Luminal staining for Evans blue demonstrated that the surgical procedure completely denuded the carotid artery (Figure 4a ). Two weeks after injury, Figure 1 Quantitative PCR analysis by the 2(ÀDDC(T)) method for (a) eNOS transcript expression from AdeNOS-transduced arteries (n ¼ 4) and (b) iNOS transcript expression from AdiNOS-transduced arteries (n ¼ 3). All values were normalized to a housekeeping gene and fold changes were calculated relative to Adb-Galtransduced controls. An increase in the number of eNOS transcripts is noted for AdeNOS-transduced arteries 1 and 4 and an increase in iNOS transcripts was detected in all AdiNOS-transduced arteries examined. Dark bars denote reactions carried out in the presence of reverse-transcriptase, light bars denote reactions carried out without reverse-transcriptase.
Comparison of eNOS and iNOS delivery on vascular injury R Cooney et al a statistical difference was detected between AdeNOStransduced (4.2173.12%, n ¼ 7) arteries and Adb-Galtransduced arteries (10.0574.97%, n ¼ 7) in terms of the area stained blue (P ¼ 0.025). Conversely a significant increase (P ¼ 0.001) in the area stained blue was detected in AdiNOS-transduced arteries (25.17711.92%, n ¼ 8) compared to AdeNOS-transduced arteries. There was also a significant difference (P ¼ 0.025) noted between Adb-Gal-transduced control arteries and Ad-iNOStransduced arteries. This demonstrates that adenoviral-mediated gene delivery of iNOS to the injured rabbit carotid artery impairs endothelial regeneration of the injured vessel whereas adenoviral-mediated delivery of eNOS improves re-endothelialization ( Figure 4b ).
Effect of eNOS and iNOS gene transfer on intimal hyperplasia
We sought to determine the effect of eNOS and iNOS overexpression on intimal hyperplasia 2 weeks after injury and gene delivery. Sections were stained with Verhoffs elastin stain and counter stained with Van Giesons stain. The neointima/media ratio was calculated for each experimental group. Two weeks after injury the 
Comparison of eNOS and iNOS delivery on vascular injury
R Cooney et al neointima/media ratios for both AdeNOS-transduced arteries (0.07270.044, n ¼ 7) and AdiNOS-transduced arteries (0.08670.086, n ¼ 7) was significantly reduced (P ¼ 0.002 for both) compared to Adb-Gal-transduced arteries (0.33270.135, n ¼ 7). These figures demonstrate the ability of both eNOS and iNOS gene delivery to markedly inhibit neointima formation in the denuded rabbit carotid artery ( Figure 5 ).
Discussion
Increased smooth muscle cell proliferation and impaired endothelial function play important roles in the pathological repair of injured vessels following angioplasty procedures. 2, 3 Diminished production of vasculoprotective mediators such as NO is a major contributory factor in this pathological process. We hypothesized that adenoviral-mediated gene transfer of NOS genes to the injured carotid artery would increase NO bioavailability within the vessel wall which in turn would enhance endothelial regeneration and inhibit intimal hyperplasia. In the present study, we examined adenoviral-mediated gene delivery of two NOS isoforms, eNOS and iNOS and also the reporter gene b-Gal to the denuded rabbit carotid artery. We observed an increase in the level of eNOS and iNOS transcripts in the majority of appropriately transduced arteries (5/7). In addition, to confirm protein expression, we detected positive eNOS, iNOS and b-Gal staining in both the media and adventitia of the injured carotid artery following adenoviral-mediated gene transfer. We also demonstrated, by histological staining that both eNOS and iNOS overexpression in the injured vessel wall inhibit neointima formation following denudation with a balloon catheter. Finally, we report that adenoviral-mediated gene delivery of iNOS significantly inhibited endothelial regeneration compared to b-Gal-treated rabbits while eNOS gene transfer significantly enhanced re-endothelialization following injury.
Previously published data has demonstrated the efficacy of gene therapy approaches to inhibiting neointimal formation with a variety of gene delivery methods and a variety of genes of interest. [17] [18] [19] [20] These studies have shown that the intervention resulted in a reduction of neointima formation but did not examine the effect on re-endothelialization. Delivery of NOS genes to the vasculature is a rational approach for a number of vascular diseases as NO has a number of antiatherogenic properties such as inhibition of smooth muscle cell proliferation and monocyte adhesion as well as being a potent vasodilator. In the current study, adenoviral gene delivery after vascular injury resulted in transgene expression in the media and adventitia. The viral dose used was 1 Â 10 9 PFU which is in the range of that described in the literature. 10 We demonstrate that adenoviral-mediated gene transfer of both eNOS and iNOS results in NOS protein expression within the injured rabbit carotid artery, leading to inhibition of neointimal formation following arterial denudation. The reduction of arterial thickening is presumably due to the ability of NO to inhibit smooth muscle cell proliferation, a result which is consistent with previously published in vitro [21] [22] [23] and in vivo data. [24] [25] [26] von der Leyen et al.
24
used HVJ liposomes to overexpress eNOS in the injured rat carotid artery while Varenne et al. 26 used adenoviral vectors to delivery eNOS to pigs following coronary angioplasty. Both studies reported similar beneficial results on neointmal hyperplasia to the present study. Similarly, Shears et al. 27 demonstrated that adenoviral- Comparison of eNOS and iNOS delivery on vascular injury R Cooney et al mediated gene delivery of iNOS to injured pig and rat arteries resulted in reduced neointima formation. However, those papers did not examine the effect of eNOS overexpression on post-injury endothelial regeneration. In addition, this is the first report of a direct comparison of the effect of the two NOS isoforms on intimal hyperplasia with both isoforms being effective at reducing this phenomenon. While inhibiting smooth muscle cell proliferation and migration as a means of improving post-angioplasty restenosis has for some time been a target for many investigators, strategies that promote endothelial regeneration have received comparatively little attention. 5 Recently published data has demonstrated that promoting re-endothlialization via a cell therapy approach in the denuded rabbit carotid artery may also have beneficial effects in terms of inhibiting intimal hyperplasia 4, 28 and improving vascular reactivity. 29 Similarly we demonstrate here that eNOS overexpression improved re-endothlialization and in addition reduced intimal hyperplasia while iNOS overexpression in the injured carotid artery has an inhibitory effect on endothelial regeneration. This observation was interesting from a number of points of view. Firstly, it was interesting to note the marked difference the two NOS isoforms had on endothelial recovery. eNOS is known to produce smaller amounts of NO than iNOS while the isoforms also vary in their calcium dependence and their reliance on cofactors such as tetrahydrobiopterin. 30 In addition, iNOS is prone to 'uncoupling' which may stimulate it to generate superoxide anion. In previous studies, we have shown that eNOS gene delivery improved endothelial function, while iNOS impaired endothelial function in the carotid artery of the hypercholesterolemic rabbit. 12, 31 In the latter study, iNOS gene delivery resulted in increased superoxide generation in the blood vessel wall. The differences in the effects of eNOS and iNOS gene delivery on endothelial regeneration may be due to the fact that higher NO concentrations generated from the latter may inhibit endothelial cell proliferation or that 'uncoupling' may lead to increased superoxide production and further oxidative stress within the vessel wall. The fact that iNOS overexpression inhibited neointimal formation while impairing endothelial recovery is also an interesting finding as it demonstrates that although re-endothelialization may certainly improve neointimal formation it is not an absolute requirement for the reduction of intimal hyperplasia. This finding regarding the dichotomy between re-endothelialization and neointimal hyperplasia is in agreement with previous reports which found increased levels of NOS substrates inhibit neointimal hyperplasia but do not enhance Comparison of eNOS and iNOS delivery on vascular injury R Cooney et al re-endothelialization. 32 The situation is analogous to drug eluting stents which reduce intimal hyperplasia but impair endothelial regeneration. In agreement with the findings of Six et al. 32 our results would also argue for a role for NO in re-endothelialization. Previous studies have monitored changes in endogenous NOS isoform and superoxide dismutase (SOD) in response to balloon injury in the rabbit. 33, 34 Consistent with the findings of our study they suggest that NO production in response to injury may prevent neointimal hyperplasia while simultaneously the SOD may protect the levels of NO produced from combination with NO to form peroxynitrite.
In conclusion, we directly compared the therapeutic effect of eNOS and iNOS gene delivery in a model of endothelial denudation for the first time and demonstrated the ability of adenoviral-mediated gene transfer of both NOS isoforms to inhibit intimal hyperplasia in the injured rabbit carotid artery. In addition eNOS overexpression enhanced endothelial regeneration whereas iNOS had an inhibitory effect, compared with controls. Our results highlight the potential for gene therapy strategies aimed at vascular expression of NOS isoforms but suggest that eNOS may have advantages in terms of a beneficial effect on re-endothelialization compared to iNOS.
Methods
Construction, propagation and purification of adenoviral vectors
A recombinant adenovirus encoding the bovine eNOS gene driven by the cytomegalovirus promoter was generated as previously described. 21 Virus was purified by double cesium chloride gradient ultracentrifugation and was dialyzed against 10 mmol/l Tris, 1.0 mmol/l MgCl 2 , 1.0 mmol/l HEPES and 10% glycerol for 4 h at 41C. Viral titer was determined by plaque assay. A recombinant adenoviral vector encoding the human iNOS gene driven by the cytomegalovirus promoters was a kind gift of Imre Kovesdi, Genvec and was generated as previously described. 23 A recombinant replication defective adenoviral vector encoding the Escherichia coli b-Gal gene driven by the CMV promoter was used as a negative control. It was propagated, isolated and titred as above. Viral stocks were stored at À801C.
Animals
All studies involving animals were approved by the Institutional Animal Care and Use Committee in accordance with the appropriate legislation. A total of Figure 5 Morphometric analysis of neointimal hyperplasia in denuded rabbit carotid arteries 2 weeks after injury (a) transduced using; AdeNOS (1,4; n ¼ 7), AdiNOS (2,5; n ¼ 7) and Adb-Gal (3,6; n ¼ 7). Magnification Â 4 (1-3) and Â 20 (4-6). Arrows indicate neointima. Quantification of neointima/media ratios for AdeNOS-, AdiNOS-and Adb-Gal-transduced arteries 2 weeks after injury (*,**Po0.05) (b).
Comparison of eNOS and iNOS delivery on vascular injury R Cooney et al 68 adult male New Zealand White rabbits (2.5-3.5 kg body weight) were used in these experiments. The animals were housed individually in stainless-steel, wire-bottomed cages in a room with a 12 h light/dark cycle and controlled temperature and humidity. Rabbits were fed a standard chow diet and water ad libitum.
Rabbit carotid artery denudation and gene transfer
Animals were anesthetized with an intramuscular injection of ketamine (35 mg/kg), xylazine (5 mg/kg) and acepromazine (2.3 mg/kg). Paramedian cervical incisions were made to the anterior neck and both common carotid arteries were exposed with blunt dissection. Heparin (300 U/kg) was injected intravenously through an ear vein. Vascular clamps were applied to the proximal end of the right common carotid (RCA) and to the external right carotid artery. The right internal carotid artery was temporarily tied off using vascular ties. An arteriotomy was performed in the right external carotid artery and a deflated 3French Fogarty balloon catheter (Baxter Healthcare, Berkshire, UK) was inserted through the external carotid and passed three times along the isolated segment of the common carotid. A 24 G angiocatheter was inserted into the common carotid through the external carotid. Blood was removed from the isolated segment of the artery with a gauze wick at the open end of the angiocatheter. A second clamp was applied to the common carotid directly proximal of the bifurcation. Adenoviral vectors encoding eNOS, iNOS or b-Gal (200 ml of 1 Â 10 9 PFU/ml) were then instilled intraluminally via the catheter, the catheter was removed and the viral vectors were allowed to dwell for 20 min. The external carotid artery was ligated. After 20 min vascular clamps were removed and flow was restored through the internal carotid artery. The left carotid arteries (LCA) that did not undergo any arteriotomy served as internal controls.
Histochemical and immunohistochemical analysis of gene expression
For histochemical staining of b-Gal expression arteries were harvested 3 days following gene delivery. Arterial rings were then fixed in 4% paraformaldehyde and 0.4% gluteraldehyde for 15 min at 41C and then rinsed twice with PBS. Rings were then stained in a solution of 500 mg/ml 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal; Boehringer-Mannheim Biochemicals, Mannheim, Germany) overnight at 371C. Arterial rings were then embedded in OCT (Tissue-Tek) and 5 mm cross sections were then cut and placed on slides. The sections were then stained with eosin. Arteries examined en face were stained using the X-Gal solution described above.
For immunohistochemical staining of eNOS and iNOS expression, harvested arteries (n ¼ 4 for each group) embedded in OCT compound had serial 5 mm cross sections taken and placed on slides. After immersion fixation in acetone (41C) and drying, the slides were incubated in 0.1% sodium azide/0.3% hydrogen peroxide and then incubated with 5% goat serum/PBSTween 20 to block nonspecific protein-binding sites. eNOS and iNOS monoclonal antibodies (both 1:50 dilution; Transduction Laboratory, Lexington, KY, USA) were applied for 60 min to appropriate slides for 2 h at room temperature, followed by incubations with biotinylated rabbit anti-mouse F(ab 0 ) 2 secondary antibody (1:200, incubation time 1 h; DAKO) and peroxidase-conjugated streptavidin (1:200, incubation time 1 h; DAKO). eNOS immunoreactivity was visualized with diaminobenzidine and hematoxylin counterstaining.
Quantitative reverse transcriptase PCR analysis of gene expression RNA was extracted from rabbit arteries 1 week following exposure to AdeNOS, AdiNOS or Adb-Gal (n ¼ 4, 3 and 2, respectively) using the RNeasy kit (Qiagen, Crawley, UK). RNA samples were treated with DNase (Invitrogen, Paisley, UK) to remove any contaminating viral genome or genomic DNA.
RNA (200 ng) was subjected to quantitative PCR with and without reverse transcription using the Quantitect SYBR Green RT-PCR kit (Qiagen) in conjunction with the ABI 7000 Sequence detection system (ABI). (501C, 30 min; 941C, 15 min; 35 cycles of 941C, 15 sec; 601C 1 min). PCR products were visualized on agarose gels. Relative expression levels were calculated using the 2(ÀDDC(T)) method 35 using hypoxanthine phosphoribosyltransferase (HPRT) expression to normalize RNA levels and comparing NOS isoform expression in arteries transduced with AdiNOS or AdeNOS with that of AdbGal-treated arteries.
PCR primers were designed to amplify bovine eNOS or human iNOS without amplifying endogenous rabbit orthologs. Bovine eNOS (NM_181037) 5 0 -GAGAGGCTG CATGACATTGAGA-3 0 and 5 0 -GGTAGAGATGGTCGA GTTGGGA-3 0 expected product size 94 bp. Human iNOS (NM_000625) 5 0 -GACTCACAGCCTTTGGACCTCA-3 0 and 5 0 -GGCTGGATGTCGGACTTTGTA-3 0 , expected product size 109 bp. Primers were also designed for a rabbit house keeping gene HPRT according to the report of Lund et al. 36 (AF020294) 5 0 -CTCAACCTTAACTGGA AAGAATGTC-3 0 and 5 0 -CCTTTTCACCAGCAGGCT-3 0 , expected product size 135 bp. 36 
Assessment of endothelialization
Two weeks after carotid artery injury, animals were anesthetized as above and given an intravenous injection of 5 ml of 0.5% Evans blue (Sigma Chemical Co., St Louis, MO, USA). After 30 min, rabbits were euthanized by intravenous injection of 2 ml of Dolethal. Harvested arteries (n ¼ 7 for the Adb-Gal and AdeNOS groups and n ¼ 8 for the AdiNOS groups) were immediately incised longitudinally to expose the luminal surface and rinsed with a cold, (41C) modified Krebs solution with the following composition (in mM): 1.2 KH 2 PO 4 , 4.7 KCl, 2.5 CaCl 2 , 1.2 MgSO 4 , 25 NaHCO 3 , 118.3 NaCl and 11.1 dextrose. Photographs of the carotid artery en face were taken. The areas with (non-Evans blue-stained area) and without endothelium (Evans blue-stained area) were analyzed using Image J software.
Morphometric analysis of intimal hyperplasia
Assessment of neointimal hyperplasia was carried out 2 weeks after arterial denudation. Following immersion in 30% sucrose for 2 h and fixation in 4% paraformaldehyde harvested arterial rings were frozen in OCT compound. Cross-sections (5 mm) were cut onto slides. Intimal hyperplasia was visualized by staining slides with Verhoffs elastin stain and counter stained with Van
Comparison of eNOS and iNOS delivery on vascular injury R Cooney et al Giesons stain. Four random cross-sections from each artery were analyzed (n ¼ 7 for each experimental group). The neointima/media ratio was calculated at eight random points on each cross section using analySIS (Soft Imaging System) image analysis software by a blinded observer.
Statistical analysis
Data is presented as the mean7s.d. An ANOVA test was used to detect global differences between the treatments. Such differences were then further examined between the groups using a t-test. P-values of o0.05 were considered statistically significant.
